145have evolved as components of the homeostatic control of cardiac function in verte-
brates during evolutionary transitions.
References
Aardal S, Helle KB (1992) The vasoinhibitory activity of bovine chromogranin A fragment
(vasostatin) and its independence of extracellular calcium in isolated segments of human blood
vessels. Regul Pept 41:9–18
Aardal S, Helle KB, Elsayed S, Reed RK, Serck-Hanssen G (1993) Vasostatins, comprising the
N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel seg-
ments. J Neuroendocrinol 5:405–412
Ai T, Horie M, Obayashi K, Sasayama S (1998) Accentuated antagonism by angiotensin II on
guinea-pig cardiac L-type Ca-currents enhanced by b-adrenergic stimulation. Eur J Phys
436:168–174
Angelone T, Quintieri AM, Brar BK, Limchaiyawat PT, Tota B, Mahata SK, Cerra MC (2008) The
antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modu-
lator of cardiac inotropism and lusitropism. Endocrinol 149:4780–4793
Angelone T, Quintieri AM, Pasqua T, Filice E, Cantafio P, Scavello F, Rocca C, Mahata SK, Gattuso
A, Cerra MC (2015) The NO stimulator, Catestatin, improves the Frank-Starling response in
normotensive and hypertensive rat hearts. Nitric Oxide 50:10–19
Banks P, Helle K (1965) The release of protein from the stimulated adrenal medulla. Biochem
J 97:40C–41C
Barkatullah SC, Curry WJ, Johnston CF, Hutton JC, Buchanan KD (1997) Ontogenetic expression
of chromogranin A and its derived peptides, WE-14 and pancreastatin, in the rat neuroendo-
crine system. Histochem Cell Biol 107:251–257
Bartolomucci A, Possenti R, Mahata SK, Fischer-Colbrie R, Loh YP, Salton SR (2011) The extended
granin family: structure, function, and biomedical implications. Endocr Rev 32:755–797
Biswas N, Curello E, O’Connor DT, Mahata SK (2010) Chromogranin/secretogranin proteins in
murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364–384)).
Cell Tissue Res 342:353–361
de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic
response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89–94
Brekke JF, Osol GJ, Helle KB (2002) N-terminal chromogranin derived peptides as dilators of
bovine coronary resistance arteries. Regul Pept 105:93–100
Cappello S, Angelone T, Tota B, Pagliaro P, Penna C, Rastaldo R, Corti A, Losano G, Cerra
MC (2007) Human recombinant chromogranin A-derived vasostatin-1 mimics precondition-
ing via an adenosine/nitric oxide signalling mechanism. Am J Physiol Heart Circ Physiol
293:H719–H727
Cerra MC, De Iuri L, Angelone T, Corti A, Tota B (2006) Recombinant N-terminal fragments of
chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res
Cardiol 101:43–52
Corti A, Mannarino C, Mazza R, Colombo B, Longhi R, Tota B (2002) Vasostatin exert negative
inotropism in the working heart of the frog. Ann N Y Acad Sci 971:362–365
Corti A, Mannarino C, Mazza R, Angelone T, Longhi R, Tota B (2004) Chromogranin A N-terminal
fragments vasostatins-1 and the synthetic CgA 7–57 peptide act as cardiostatins on the isolated
working frog heart. Gen Comp Endocrinol 136:217–224
Deftos LJ, Björnsson BT, Burton DW, O’Connor DT, Copp DH (1987) Chromogranin A is present
in and released by fish endocrine tissue. Life Sci 40:2133–2136
Comparative Aspects of CgA-Derived Peptides in Cardiac Homeostasis